Choi Heung Kook, Yessayan Doreen, Choi Hyun Ju, Schellenberger Eyk, Bogdanov Alex, Josephson Lee, Weissleder Ralph, Ntziachristos Vasilis
Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
Cell Oncol. 2005;27(3):183-90. doi: 10.1155/2005/791936.
To microscopically analyze the chemotherapeutic response of tumors using in vivo staining based on an annexinV-Cy5.5 probe and independently asses their apoptotic count using quantitative histological analysis.
Lewis Lung Carcinomas cells, that are sensitive (CS-LLC) and resistant (CR-LLC) to chemotherapy were implanted in nude mice and grown to tumours. Mice were treated with cyclophosphamide and injected with a Cy5.5-annexinV fluorescent probe. In vivo imaging was performed using Fluorescence Molecular Tomography. Subsequently tumours were excised and prepared for histology. The histological tumour sections were stained for apoptosis using a terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL) assay. A minimum of ten tissue sections were analyzed per tumour for apoptosis quantification by TUNEL staining and corresponding Cy5.5 distribution.
We detected higher levels of apoptosis and corresponding higher levels of Cy5.5 fluorescence in the CS-LLC vs. the CR-LLC tumours. The cell count rate on CS-LLC sections over CR-LLC was found to be approximately 2 :1 where the corresponding area observed on Cy5.5 distribution measurements revealed a approximately 1.7 :1 ratio of CS-LLC over CR-LLC. These observations are consistent with the higher apoptotic index expected from the CS-LLC cell line.
Quantitative analysis of histological slices revealed higher fluorescence and higher apoptotic count in the CS-LLC tumour images compared to the CR-LLC tumour images. These observations demonstrate that the annexinV-Cy5.5 probe sensed the chemotherapeutic effect of cyclophospamide and further confirmed in vivo FMT measurements.
使用基于膜联蛋白V-Cy5.5探针的体内染色对肿瘤的化疗反应进行微观分析,并通过定量组织学分析独立评估其凋亡细胞计数。
将对化疗敏感(CS-LLC)和耐药(CR-LLC)的Lewis肺癌细胞接种到裸鼠体内并长成肿瘤。用环磷酰胺治疗小鼠,并注射Cy5.5-膜联蛋白V荧光探针。使用荧光分子断层扫描进行体内成像。随后切除肿瘤并制备用于组织学检查。使用末端脱氧核苷酸转移酶介导的缺口末端标记(TUNEL)测定法对组织学肿瘤切片进行凋亡染色。每个肿瘤至少分析十张组织切片,通过TUNEL染色和相应的Cy5.5分布进行凋亡定量。
我们在CS-LLC肿瘤中检测到比CR-LLC肿瘤更高水平的凋亡以及相应更高水平的Cy5.5荧光。发现CS-LLC切片上的细胞计数率与CR-LLC相比约为2:1,而在Cy5.5分布测量中观察到的相应区域显示CS-LLC与CR-LLC的比例约为1.7:1。这些观察结果与CS-LLC细胞系预期的更高凋亡指数一致。
组织学切片的定量分析显示,与CR-LLC肿瘤图像相比,CS-LLC肿瘤图像中的荧光更高,凋亡细胞计数也更高。这些观察结果表明,膜联蛋白V-Cy5.5探针感知到了环磷酰胺的化疗效果,并进一步证实了体内荧光分子断层扫描测量结果。